Kurser indlæses...
Prognose
Analytikernes gennemsnitlige kursmål er 149,34 € (-1,18 %). Medianen er 148,64 € (-1,64 %).
| Køb |
Â
29 |
| Behold |
Â
23 |
| Sælg |
Â
1 |
Diskussioner i communityet
- Umgang mit nicht-performanten Qualitätsaktien
Das_Lama III i Schnack8 55 - Gewinner laufen lassen/ Schäfchen ins Trockene bringen
Parqet Nutzer II i Schnack
0 8 - Regelmäßige Dividenden
Bakterius II i Schnack1 61 - Eine Aktie fĂĽr die Ewigkeit! Welche wĂĽrdet ihr nehmen?
MB Marc B. IV i Schnack
2 20 - Einzeltitel gesucht!
Schwoab I i Schnack
0 5
Nyheder Til nyhedsfeedet
Procter & Gamble confirms profit forecast despite sharply higher costs
In the first fiscal quarter 2026/27, Procter & Gamble’s revenue rose 4.0% to USD 23.28 billion, with organic growth (adjusted) also at 4.0%; adjusted earnings per share climbed to USD 2.00 and beat expectations. The adjusted EBIT margin fell from 26.7% to 25.9% due to significantly higher raw material and transportation costs. Management slightly raised the sales outlook (2–4%), confirmed the adjusted EPS guidance of USD 6.89–7.11, and plans share buybacks and dividend payments of several billion dollars each; at the same time, higher raw material, interest and currency effects weighed on results. » Mere på finanzen.net
Procter & Gamble starts the 2026/27 fiscal year strongly
The US consumer goods giant Procter & Gamble reported organic sales growth of 4% to $23.3 billion for the three months ended September, driven mainly by volumes with only modestly higher prices. Net income was about $4.7 billion, roughly flat year-on-year, and adjusted earnings per share rose 1% to $2.00. P&G confirmed its full-year targets: adjusted EPS to be flat to +3% ($6.89–$7.11) and organic sales growth of 1–3%; including the acquisition of Thorne, sales are expected to increase 2–4%. The stock rose just over 5% in early trading. » Mere på finanzen.net
Procter & Gamble hits 70th consecutive annual dividend increase amid steady fiscal 2026 results
Procter & Gamble extended its dividend streak to 70 years and yields nearly 3%, supported by fiscal 2026 revenue of about $87 billion (up 3%) and EPS of $6.62 (up 2%). Moody's upgraded the company's credit outlook to positive, citing sustainable free cash flow and earnings growth. The stock is down roughly 8% year‑over‑year and trades at forward and trailing P/E ratios above 20, suggesting it is not inexpensive despite the reliable payout. » Mere på finance.yahoo.com
Moody’s raises outlook for Procter & Gamble to positive after strong cash flow
Moody’s has confirmed the ratings for Procter & Gamble and Gillette (Aa3/Prime-1) and has raised the rating outlook from stable to positive. The change is justified by sustained free cash flow, strong earnings growth driven by price increases, innovation and cost reductions, and solid credit metrics (retained cash flow/net debt well above 25%, debt/EBITDA below 2). The acquisition of Thorne for USD 3.8 billion will pro forma temporarily increase the leverage ratio to just above 1.6x, but is expected to decline again through integration, scale effects and cost optimization. Moody’s cites potential upgrades or downgrades depending on market shares, profitability, free cash flow and the company’s financial policy. » Mere på de.investing.com
L Catterton sells Thorne to Procter & Gamble for $3.8 billion
L Catterton has signed a definitive agreement to sell Thorne to Procter & Gamble for a cash price of $3.8 billion. L Catterton entered Thorne in October 2023, strengthened leadership, marketing, sales, R&D and technological infrastructure, and promoted AI-enabled offerings. The transaction is expected to close in the fourth quarter of 2026; Perella Weinberg Partners and Canaccord Genuity advised Thorne, and Kirkland & Ellis and Jones Day acted as legal counsel. » Mere på de.investing.com
Historisk udbytte Udbytte
Alle nøgletal for udbytte Alle nøgletalVirksomhedstal
| (EUR) | september 2026 | YoY |
|---|---|---|
| Omsætning | 20,55 mia. | 7,72 % |
| Bruttofortjeneste | 10,24Â mia. | 4,50Â % |
| Nettoresultat | 4,18Â mia. | 3,19Â % |
| EBITDA | 6,23Â mia. | 4,55Â % |
Fundamentale data
| Nøgletal | Værdi |
|---|---|
Markedsværdi | 343,28 mia. € |
Antal aktier | 2,32Â mia. |
Højeste/laveste i 52 uger | 152,69 € - 123,23 € |
Udbytteafkast | 2,45Â % |
Udbytte TTM | 3,68 € |
Næste udbytte | 0,97 € |
Beta | 0,36 |
P/E (PE Ratio) | 24,50 |
PEG (PEG Ratio) | -6,15 |
K/I (PB Ratio) | 7,23 |
P/S (PS Ratio) | 4,36 |
Virksomhedsprofil
The Procter & Gamble Company leverer mærkevarer inden for forbrugeremballerede varer til forbrugere i Nord- og Latinamerika, Europa, Asien-Stillehavsregionen, Greater China, Indien, Mellemøsten og Afrika. Virksomheden opererer i fem segmenter: Beauty; Grooming; Health Care; Fabric & Home Care; og Baby, Feminine & Family Care. Beauty-segmentet tilbyder conditionere, shampoo, stylingprodukter og behandlinger; samt antiperspiranter og deodoranter, personlig rensning og hudplejeprodukter under mærkerne Head & Shoulders, Herbal Essences, Pantene, Rejoice, Olay, Old Spice, Safeguard, Secret og SK-II. The Procter & Gamble Company blev grundlagt i 1837 og har hovedkontor i Cincinnati, Ohio.
| Navn | Procter & Gamble |
| CEO | Shailesh G. Jejurikar |
| Hjemsted | Cincinnati,
oh USA |
| Websted | |
| Sektor | Dagligvarer |
| Branche | Husholdningsprodukter |
| Børsnotering | 02.01.1962 |
| Medarbejdere | 104.000 |
Tickersymboler
| Børs | Symbol |
|---|---|
NYSE | PG |
XETRA | PRG.DE |
Frankfurt | PRG.F |
DĂĽsseldorf | PRG.DU |
Hamburg | PRG.HM |
Milan | 1PG.MI |
London | 0NOF.L |
SIX | PG.SW |
MĂĽnchen | PRG.MU |
Wien | PG.VI |